Regulacje i polityka gospodarcza · 30/11/2018

340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation

The Health Resources and Services Administration (HRSA) administers the 340B Drug Pricing Program, which sets the ceiling price for discounted medications. The program's effective date was delayed several times before being finalized on January 1, 2019, following extensive public comment and rulemaking.